Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Ivy

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Oncology (Williston Park, N.Y.)|February 24, 2001
NCI cooperative research and development agreementsS P Ivy
Oncology (Williston Park, N.Y.)|September 28, 1999
Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|August 12, 1999
Clinical trials referral resource. Clinical trials of single-agent oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|June 5, 1999
Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrinS P Ivy, G Blatner, B D Cheson
Leukemia Research|October 31, 2001
Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cellsB J Taylor, D P Olson, S P Ivy
Cytometry|April 20, 2001
Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrateD P Olson, B J Taylor, S P Ivy
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Multidrug resistanceJ A Moscow, E Schneider, S P Ivy, et al.
The Journal of Pediatrics|November 1, 1995
Demodicidosis in childhood acute lymphoblastic leukemia; an opportunistic infection occurring with immunosuppressionS P Ivy, C L Mackall, L Gore, et al.
Leukemia|July 1, 1997
Sensitization of multidrug-resistant human leukemia cells with MDR1-targeted antisense and inhibition of drug-mediated MDR1 inductionX Li, A P Smyth, D J Barrett, et al.
Cancer|June 15, 1997
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical CenterJ A Ortega, S S Donaldson, S P Ivy, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|February 24, 2001
NCI cooperative research and development agreementsS P Ivy
Oncology (Williston Park, N.Y.)|September 28, 1999
Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|August 12, 1999
Clinical trials referral resource. Clinical trials of single-agent oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|June 5, 1999
Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrinS P Ivy, G Blatner, B D Cheson
Leukemia Research|October 31, 2001
Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cellsB J Taylor, D P Olson, S P Ivy
Cytometry|April 20, 2001
Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrateD P Olson, B J Taylor, S P Ivy
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Multidrug resistanceJ A Moscow, E Schneider, S P Ivy, et al.
The Journal of Pediatrics|November 1, 1995
Demodicidosis in childhood acute lymphoblastic leukemia; an opportunistic infection occurring with immunosuppressionS P Ivy, C L Mackall, L Gore, et al.
Leukemia|July 1, 1997
Sensitization of multidrug-resistant human leukemia cells with MDR1-targeted antisense and inhibition of drug-mediated MDR1 inductionX Li, A P Smyth, D J Barrett, et al.
Cancer|June 15, 1997
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical CenterJ A Ortega, S S Donaldson, S P Ivy, et al.
Pageof 3